Photon computed tomography is similar to MRI for evaluating fatty liver disease

Published Date: 01 Mar 2023

USA: For the evaluation of hepatic steatosis in obese patients, photon computed tomography (PCCT) is as effective as magnetic resonance imaging (MRI).

Read Full News

Latest News

Jun 19 2026 This Week in Cardiology

Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD, discusses in this week’s podcast.

Planning Pregnancy in Crohn’s: Expert Insights

Dr Laura Sahyoun discusses the challenges of pregnancy in Crohn’s disease, with clinical guidance to help optimize care.

The Vascular Etiology of Migraine Myth

Neurologist Indu Subramanian asks migraine expert Andrew Charles how the vascular hypothesis emerged and what the imaging studies really show.

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Jun 05 2026 This Week in Cardiology

Managing Localized Uveal Melanoma: New Guideline Review

Dr Teresa Amaral reviews new guidelines for localized uveal melanoma, covering enucleation, radiotherapy nuances, and the current evidence on adjuvant systemic treatment.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Latest News

Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD, discusses in this week’s podcast.

Dr Laura Sahyoun discusses the challenges of pregnancy in Crohn’s disease, with clinical guidance to help optimize care.

Neurologist Indu Subramanian asks migraine expert Andrew Charles how the vascular hypothesis emerged and what the imaging studies really show.

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Dr Teresa Amaral reviews new guidelines for localized uveal melanoma, covering enucleation, radiotherapy nuances, and the current evidence on adjuvant systemic treatment.

News All Time

More Evidence Backs AI-Supported Mammography

Interval cancer rates were noninferior versus standard double reading by radiologists

'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer

But an association with improved overall survival failed to reach statistical significance

Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging

Will AI Replace Physicians? Can Prior Auth Be Fixed? A Q&A With HHS's Health IT Czar

Thomas Keane talks about artificial intelligence and other challenges facing his agency

First-of-Its-Kind Device for Pancreatic Cancer Wins FDA Approval

First approved therapy for locally advanced disease in almost three decades

Stereotactic Radiation Better for Patients With Multiple Brain Metastases?

Symptom severity, interference with daily functioning were improved

Should We Do a Shoulder MRI? Food Prescriptions for Diabetes

Also in TTHealthWatch: a planetary health diet, and patient views of statin therapy

Reining in Overdiagnosis of Papillary Thyroid Cancer: Easier Said Than Done

Cutting ultrasound referrals for nonpalpable nodules could lead to decreases in incidence

Beware of Radiation Doses Among Heart Scanners, Study Says

Coronary CT angiography, poorer countries under scrutiny for larger doses

Study Questions Use of Prostate Cancer Hormone Therapy in Certain Cases

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients

Routine Mammograms That Also Flag CVD: Two Birds With One Stone?

AI-driven quantification of breast arterial calcification on imaging could ID higher-risk women

Tiny Blood Smidges in the Brain: Amount and Location Tied to Dementia

Neuroimaging findings believed to arise from distinct pathologies

Even Patients Are Shocked by the Prices Their Insurers Will Pay

And it costs all of us

Lead Suits Cut Physician Radiation Exposure for Interventional Cardiology Cases

Median exposure reduced to 0 versus lead apron during LAAO, with possible broader applicability

Ultrasound Treatment for Prostate Cancer Has Early Advantage Versus Prostatectomy

Better continence, erectile function, but data on oncologic outcomes still 2 years away

AI Strategy Could Eliminate Radiologist Review of Low-Risk Mammograms

Approach cut workload by 64% and increased cancer detection rate versus standard strategy

Recommended News For You

Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests

automated, precise reporting for clonality testing using NGS.

tobacco use, the severity of their symptoms, and their desire to give up smoking among cancer survivors.

Error on the MGUS-Autoimmune Disease Association.

For treatment, the majority of cancer patients choose complementary therapies.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

Recommended Articles For You

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies 

Synovial Sarcoma of Female Urethra: Case Report and Literature Review 

Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders 

Healthy Hematopoietic Aging and Disease Avoidance: Mechanisms, Clinical Insights, and Future Directions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.

2.

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

3.

Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.

4.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

5.

A study on lung cancer provides additional proof of the value of screening.

1.

Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients

2.

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment

3.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

4.

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring

5.

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

5.

Understanding the causes of anemia in adults beyond nutritional deficiencies

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot